ST. LOUIS, May 8, 2013 (GLOBE NEWSWIRE) -- Butcher Joseph Hayes, an investment bank specializing in ESOPs and merger and acquisition related transactions, served as exclusive financial advisor to Freedom Pharmaceuticals on its sale to Fagron, a division of Arseus NV.
"Butcher Joseph Hayes gave me the competitive advantage of having a professional, practical, and result-oriented firm on my side from start to finish," Jacob (Jake) Jackson, President of Freedom Pharmaceuticals, said. "The speed of execution and spot-on guidance that was delivered with the highest level of competency gave me the confidence I needed to close the deal of a lifetime! When you work with BJH, your deal is treated with the perfect balance of respect and aggressiveness necessary to achieve ultimate success! Game on!"
Butcher Joseph's team of experienced bankers were well positioned to support the transaction through a clear understanding of the client's objectives and the knowledge to manage the complex cross-border acquisition to a closing.
The acquisition of Freedom Pharmaceuticals, a privately held company located in Tulsa, Oklahoma, strengthens Fagron's global market leadership, creates a presence throughout the United States and allows Fagron to immediately deliver extra value to customers.
About Butcher Joseph Hayes
Butcher Joseph Hayes is an investment bank headquartered in St Louis, MO with presence in: Chicago, IL; Washington, DC; Pittsburgh, PA; Charlotte, NC and San Francisco, CA. Butcher Joseph Hayes provides investment banking advisory services to middle market companies. Butcher Joseph Hayes is also recognized for its expertise in ESOP-related transactions.
About Freedom Pharmaceuticals
Freedom Pharmaceuticals, located in Tulsa Oklahoma, is a boutique supplier of fine compounding chemicals, excipients, bases and capsules to the independent compounding pharmacy industry.